Medication Shortages in Pharmacies to Augment Growth of Global RFID in Healthcare Market

 


A radio frequency identification (RFID) tag typically uses
electromagnetic radiation to identify and track tags, which are then attached
to specific objects. RFID tags are a simple way of identifying things and have
become increasingly popular for both business and personal use. The use of RFID
offers many benefits to the healthcare industry related to patient safety,
tracking, efficiencies in patient care, and provider satisfaction.  

Market Dynamics

Medication shortages in pharmacies is expected to propel growth of
the global RFID in healthcare market. For instance, according to an annual
survey published in August 2020 by Kit Check, around 60% of pharmacy staff
reported dealing with up to 20 medication shortages at a time. More than 72 of
respondents reported spending up to 15 staff hours to reconcile each medication
shortage.

Moreover, launch of medical devices with RFID scanners is also expected
to propel growth of the global RFID in healthcare market. For instance, in
January 2020, Dentsply Sirona launched CEREC Primemill, a grinding and milling
machine with 7-inch touch interface, an integrated camera for scanning blocks
with compatible data matrix code, and an RFID scanner for reading tool
information.

High cost of the system is expected to hinder growth of the Global
RFID in healthcare market. The cost of an RFID tag can range from four
cents per tag to upwards of US$ 50.00 per tag depending on the capabilities.
The RFID tag readers can range from US$ 1,000.00 to US$ 3,000.00 per reader.

Among regions, North America is expected to witness significant
growth in the global RFID in healthcare market, owing to increasing launch of medicines
with RFID tags. For instance, in October 2020, Sandoz Inc. announced the
availability of its first two injectable medicines with Radio Frequency
Identification (RFID) tags in the U.S. through its collaboration with Kit
Check, Inc.

Major players in the global RFID in healthcare market are focused
on adopting partnership strategies to enhance their market share. For instance,
in September 2020, Kit Check, a provider of automated and intelligent
medication management solutions, signed an agreement with SCA Pharmaceuticals
that allows SCA to add an embedded RFID tag to all of its products.

Competitive Analysis

Major players operating in the global RFID in healthcare market include,
Microchip Technology, Accenture plc, Hitachi, IBM, 3M, AeroScout Inc., Know
Labs, Inc., Kit Check, Fresenius Kabi, and Siemens Healthcare.

September 2020: Kit Check signed an
agreement with SCA Pharmaceuticals that allows SCA to add an embedded RFID tag
to all of its products.





















 

Comments

Post a Comment

Popular posts from this blog

The Global Gynecological Devices Market Continues To Grow Owing To The Rising Demand For Regular Gynecological Checkups And Increasing Awareness On Women’s Health And Hygiene

Image
  A gynecological device is a medical device that is used to promote female health or to protect and preserve reproductive health for females. This is a very broad category and includes products such as watches, calculators, bandages, and hygienic towels. While many of these products have been clinically tested and found to be safe for female health, there are still a few devices in the market that pose threats to female reproductive health. Gynecological devices are usually fall into three categories: medical devices, biological safety devices, and mechanical devices. Medical devices are those that prevent the risk of injury or trauma to a woman's reproductive organs from medical interventions. Biologic safety devices are those that protect a female's health by promoting female reproductive health. Finally, mechanical devices are those that help maintain a woman's reproductive health and allow her to achieve or reach their desired fertility or pregnancy. The use of any of ...
Read more

Polyethylene Terephthalate Market Continues to Expand as British Petroleum plc signs a cooperation agreement with China Resources Chemical Materials Technology Co. Ltd to strengthen cooperation on PTA sourcing

Image
  PET is an abbreviation for polyethylene terephthalate; the material most often used in PET bottles. PET is an extremely tough plastic, which is why it's commonly used as a packaging material. PET has many advantages over other plastics, including strength, resistance to breaking and crushing, and its natural plasticity it will fill almost anything and is resistant to oil and chemicals that can cause it to break down over time. Rapid growth of the food and beverage industry is expected to drive of the global polyethylene terephthalate market growth . The food and beverage industry has witnessed significant growth in both developed and emerging economies. According to the Food and Drink Federation, the U.K., the food and drink manufacturing sector accounts for 17% in terms of economic contribution. Furthermore, according to the India Brand Equity Foundation (IBEF), the food processing industry contributed 14% of the country’s GDP in 2016. Polyethylene terephthalate or PET is widely...
Read more

Stomach Cancer Drugs Market Continues to Expand as South Korean Drug Manufacturer Celltrion Inc. Receives the WHO Prequalification Standards for its biosimilar

Image
  Stomach cancer is a growth of abnormal tissues that form a tumor in the part of your abdomen. Symptoms of stomach cancer often include persistent abdominal pain, extreme heartburn, extreme vomiting, severe indigestion, abdominal swelling, and frequent diarrhea. These symptoms are common for all forms of stomach cancer but when cancer spreads to the upper part of the chest, the symptoms become far more severe and may eventually cause death. Stomach cancer has the highest survival rate of any type of cancer in the world.  Crocetin (trade name Eulexin) is the first Stomach Cancer Drug that is used in the treatment of gastric cancer. It was later on approved for treating peritoneal mesothelioma but was not marketed extensively due to its negative outcomes at the beginning. Increasing prevalence of stomach cancer is expected to drive growth of the global stomach cancer drugs market during the forecast period. According to the American Cancer Society (ACS), in 2020, around 27,600...
Read more